Narayana Hrudayalaya Ltd
NSE:NH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 148.1
1 416.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd
Cost of Revenue
Narayana Hrudayalaya Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Cost of Revenue
-₹20.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
|
Cost of Revenue
-₹11.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Cost of Revenue
-₹98.1B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Cost of Revenue
-₹16.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Cost of Revenue
-₹11.2B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Cost of Revenue
-₹7.6B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Narayana Hrudayalaya Ltd
Glance View
Narayana Hrudayalaya Ltd. engages in the provision of medical and health care services. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-01-06. The firm operates a network of hospitals, diagnostic centers, clinical centers or test laboratories. The firm operates through Medical and Healthcare Services business segment. The firm offers medical, surgery, and diagnostics and support services. The company provides services in the areas of cardiology; orthopedics; cosmetic surgery; anesthesia; imaging and radiology; nutrition and dietetics; physiotherapy; renal transplant; thoracic surgery; pediatrics surgery; medical oncology; surgical gastroenterology; dermatology; hematology; rheumatology; neurology; psychiatry and psychology, and others. The firm operates a network of approximately 20 hospitals (multispecialty and super specialty healthcare facilities), four heart centers and 19 primary care facilities (including clinics and information centers), across India and a hospital at Cayman Islands with approximately 6,181 operational beds.
See Also
What is Narayana Hrudayalaya Ltd's Cost of Revenue?
Cost of Revenue
-20.4B
INR
Based on the financial report for Sep 30, 2024, Narayana Hrudayalaya Ltd's Cost of Revenue amounts to -20.4B INR.
What is Narayana Hrudayalaya Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-8%
Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Narayana Hrudayalaya Ltd have been -12% over the past three years , -8% over the past five years .
You don't have any saved screeners yet
